Curanex Pharmaceuticals reported net income of -$3.29M for the quarter ended Jun 2026. This income statement covers 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2024 | Dec2024 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|
| Operating items | ||||||
| Research & DevelopmentR&D | 0.68M | 2.98M | 2.59M | |||
| Selling, General & AdministrativeSG&A | 0.09M | 0.07M | 0.06M | 0.27M | 0.79M | 0.73M |
| Other Operating ExpensesOther Opex | 0.07M | -0.68M | ||||
| Operating ExpensesOpex | 0.09M | 0.15M | 0.06M | 0.95M | 3.09M | 3.33M |
| Operating IncomeOp. Inc | -0.09M | -0.15M | -0.06M | -0.95M | -3.09M | -3.33M |
| EBIT | -0.09M | -0.15M | -0.06M | -0.95M | -3.09M | -3.33M |
| Non-operating items | ||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | ||||
| Other Non Operating IncomeOther Non Op Inc. | 0.00M | 0.00M | 403.00 | 0.00M | 0.02M | 0.03M |
| Net income details | ||||||
| EBT | -0.09M | -0.15M | -0.06M | -0.96M | -3.09M | -3.33M |
| Profit After TaxPAT | -0.09M | -0.15M | -0.06M | -0.95M | -3.07M | -3.29M |
| Income from Continuing OperationsIncome (Continuing) | -0.09M | -0.15M | -0.06M | -0.96M | -3.09M | -3.33M |
| Consolidated Net IncomeConsol Net Inc. | -0.09M | -0.15M | -0.06M | -0.96M | -3.09M | -3.33M |
| Income towards Parent CompanyParent Net Inc | -0.09M | -0.15M | -0.06M | -0.96M | -3.09M | -3.33M |
| Net Income towards Common StockholdersNet Income | -0.09M | -0.15M | -0.06M | -0.96M | -3.09M | -3.33M |
| Additional items | ||||||
| EPS (Basic) | -0.44 | -0.22 | -0.05 | -0.75 | -2.43 | -2.34 |
| EPS (Diluted) | -0.44 | -0.22 | -0.05 | -0.75 | -2.43 | -2.34 |
| Shares Outstanding | 0.21M | 0.66M | 1.20M | 1.28M | 1.27M | 1.42M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.21M | 0.66M | 1.20M | 1.28M | 1.27M | 1.42M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.21M | 0.66M | 1.20M | 1.42M | 1.42M | 1.42M |
| EBITDA | -0.09M | -0.15M | -0.06M | -0.95M | -3.09M | -3.33M |
| Interest ExpensesInt Expense | 0.00M | 0.00M |